Artificial Intelligence

A little-known platform rocketed from $420k to $1.5B in three years. We explore the powerful tech engine behind this explosive rise in wealth management.

The deal merges a leading health data platform with mobile diagnostics, aiming to remove barriers to proactive wellness and deliver lab tests anywhere.

Jordan Foster Construction's latest award reveals a deeper trend: integrating mental health and AI to redefine safety in a high-risk industry.

With its lead drug in Phase 3 and a strong Biogen partnership, Stoke Therapeutics prepares to update investors on its disease-modifying Dravet syndrome therapy.

A new study reveals why GLP-1 drugs work for some and not others. 23andMe's research could personalize obesity treatment for millions of patients.

A single-dose therapy wiped out aggressive glioblastoma tumors in a landmark pre-clinical study, paving the way for human trials in 2026.

As AI and automation reshape global tax, a new online certificate from IBFD and VU Amsterdam aims to equip professionals with crucial, future-proof skills.

A new report reveals a massive security blind spot. Unmanaged apps, fueled by AI adoption, are causing data breaches, audit failures, and huge financial losses.

Sweed hires tech growth expert Brad Cross as CRO, signaling a major push to dominate the dispensary tech market with its all-in-one AI platform.

A major upgrade to RxERP's platform introduces unit-level audit logging, promising to redefine data integrity and drive efficiency beyond simple compliance.

A new app lets users bet on viral videos, raising over $1M to financialize social media. But does it create a new economy or a new set of risks?

In 2025, a non-profit delivered 53,000 hours of free virtual programs, from pet painting to yoga, creating a new blueprint for aging well.

With B2B firms struggling to execute strategy, 2X appoints Emily Atkinson as CCO to operationalize its unified GTM engine and close the widening gap.

Progressive Grocer’s annual awards name 68 top products, revealing key trends in sustainability, wellness, and global flavors shaping our grocery carts.

The WODMDX 2026 expo returns to Shanghai, leveraging a unique 'precision matching' model to connect global tech with China's industrial giants.

Retired NASA astronaut and UMD alumna Dr. Jeanette Epps will inspire the Class of 2026, bringing her story of 'fearless determination' back to campus.

Absci will showcase its generative AI drug discovery platform at a key healthcare conference, highlighting its ambitious pipeline for hair loss and endometriosis.

With stellar trial data for its cholesterol drug obicetrapib, NewAmsterdam Pharma faces investors as it navigates a competitive market and awaits key results.

As uranium prices soar, one explorer uses advanced 3D modeling and AI to unlock new discovery potential in Canada's richest uranium district.

As Spectral AI preps its revolutionary DeepView wound scanner for launch, new CFO David McGuire brings crucial public company expertise to a pivotal transition.